Literature DB >> 24169133

Assessment of self-expanding nitinol stent deformation after chronic implantation into the femoropopliteal arteries.

Alexander Nikanorov1, Martin Schillinger, Hugh Zhao, Erich Minar, Lewis B Schwartz.   

Abstract

AIMS: The purpose of this prospective clinical investigation was to quantify the degree and range of compressive and bending deformations sustained by self-expanding nitinol stents when implanted into the femoropopliteal arteries of patients with symptomatic peripheral vascular disease (PVD). METHODS AND
RESULTS: Twenty-three nitinol self-expanding stents (Absolute; Abbott Vascular, Santa Clara, CA, USA) with diameters ranging from 5-10 mm and lengths ranging from 40-100 mm were implanted in 19 lesions in 18 extremities of 17 patients. Two days following implantation, in vivo stent compression and bending were assessed by measurement of stent length and deflection angle via lateral view radiographs. The results showed that leg flexion was associated with significant stent bending; popliteal stents bent almost 90° while SFA stents bent only minimally. Leg flexion was also associated with stent shortening (compression), the greatest amount being observed for stents implanted into the popliteal artery (popliteal 8.5% ± 3.2%; SFA/prox pop 5.3% ± 0.5%; SFA 3.1% ± 1.8%). After a mean follow-up of 7.1 ± 1.3 months, the degree of stent deformation during leg flexion was essentially unchanged as compared to immediate post-procedure levels.
CONCLUSIONS: Indwelling nitinol stents are routinely bent and compressed during leg flexion, with most bending observed in stents implanted near the popliteal artery. The degree of deformation observed immediately after implantation appears to be predictive of the chronic state, as repeat measurements obtained after a mean of seven months were essentially unchanged from baseline.

Entities:  

Mesh:

Year:  2013        PMID: 24169133     DOI: 10.4244/EIJV9I6A117

Source DB:  PubMed          Journal:  EuroIntervention        ISSN: 1774-024X            Impact factor:   6.534


  7 in total

1.  Cross-sectional pinching in human femoropopliteal arteries due to limb flexion, and stent design optimization for maximum cross-sectional opening and minimum intramural stresses.

Authors:  Anastasia Desyatova; William Poulson; Jason MacTaggart; Kaspars Maleckis; Alexey Kamenskiy
Journal:  J R Soc Interface       Date:  2018-08       Impact factor: 4.118

2.  Validating Fatigue Safety Factor Calculation Methods for Cardiovascular Stents.

Authors: 
Journal:  J Biomech Eng       Date:  2018-06-01       Impact factor: 2.097

Review 3.  Nitinol Stents in the Femoropopliteal Artery: A Mechanical Perspective on Material, Design, and Performance.

Authors:  Kaspars Maleckis; Eric Anttila; Paul Aylward; William Poulson; Anastasia Desyatova; Jason MacTaggart; Alexey Kamenskiy
Journal:  Ann Biomed Eng       Date:  2018-02-22       Impact factor: 3.934

4.  Stent Design Affects Femoropopliteal Artery Deformation.

Authors:  Jason MacTaggart; William Poulson; Andreas Seas; Paul Deegan; Carol Lomneth; Anastasia Desyatova; Kaspars Maleckis; Alexey Kamenskiy
Journal:  Ann Surg       Date:  2019-07       Impact factor: 13.787

5.  Nitinol Self-Expanding Stents for the Treatment of Obstructive Superficial Femoral Artery Disease: Three-Year Results of the RELIABLE Japanese Multicenter Study.

Authors:  Masato Nakamura; Michael R Jaff; Richard A Settlage; Kimihiko Kichikawa
Journal:  Ann Vasc Dis       Date:  2018-09-25

6.  Prediction of restenosis based on hemodynamical markers in revascularized femoro-popliteal arteries during leg flexion.

Authors:  Can Gökgöl; Nicolas Diehm; Lorenz Räber; Philippe Büchler
Journal:  Biomech Model Mechanobiol       Date:  2019-06-13

7.  Intravascular treatment of long segments of experimental peripheral arteries with multiple, serial, balloon-expandable, resorbable scaffolds.

Authors:  Rym El Khoury; Ivan Tzvetanov; Edward A Estrada; Edward McCarroll; Eugene Michal; Jack Blumeyer; Louis-Georges Guy; Martin Laflamme; Lewis B Schwartz
Journal:  JVS Vasc Sci       Date:  2022-03-28
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.